Biodesix (BDSX) Current Assets (2019 - 2026)

Biodesix (BDSX) has reported Current Assets for 8 consecutive years, with $40.9 million the latest figure, recorded in Q1 2026.

• Current Assets for Q1 2026 came in at $40.9 million, up 38.11% year-over-year; the trailing twelve-month figure through Mar 2026 was $40.9 million (up 38.11% YoY), and the FY2025 annual result was $32.5 million, down 17.64% from the prior year.
• Current Assets was $40.9 million for Q1 2026 at Biodesix, up from $32.5 million in the prior quarter.
• Over five years, Current Assets peaked at $57.6 million in Q2 2024 and troughed at $24.1 million in Q3 2022.
• Average Current Assets over 5 years is $35.7 million, with a median of $33.4 million recorded in 2025.
• Year-over-year, Current Assets sank 66.48% in 2022 and surged 128.08% in 2024.
• Over 5 years, Current Assets stood at $53.3 million in 2022, then decreased by 25.6% to $39.7 million in 2023, then fell by 0.5% to $39.5 million in 2024, then decreased by 17.64% to $32.5 million in 2025, then rose by 25.81% to $40.9 million in 2026.
• Per Business Quant data, the three most recent Current Assets figures were $40.9 million in Q1 2026, $32.5 million in Q4 2025, and $33.4 million in Q3 2025.